Basics Embecta Corp. IPO Date: April 1, 2022 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $559.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.20% Avg Daily Range (30 D): $0.25 | 2.46% Avg Daily Range (90 D): $0.30 | 2.59% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .44M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 61 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 1,325 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $1.84M Avg Inst. Trade (90 D): $1.57M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.54M Avg Closing Trade (30 D): $1.87M Avg Closing Trade (90 D): $1.6M Avg Closing Volume: 115.66K     News May 27, 2025 @ 9:00 PM embecta to Participate in Investor Events Source: N/A May 9, 2025 @ 10:00 AM embecta Announces Quarterly Cash Dividend Source: N/A Apr 21, 2025 @ 9:00 PM embecta to Report Fiscal Second Quarter 2025 Finan... Source: N/A Feb 18, 2025 @ 10:00 PM embecta to Participate at the J.P. Morgan Global L... Source: N/A Feb 6, 2025 @ 3:24 PM Becton Dickinson Q1 Earnings: Revenue And EPS Beat... Source: Vandana Singh Financials   TTM Q2 2025 Q1 2025 Basic EPS $.9 $.4 $ Diluted EPS $.89 $.4 $ Revenue $ 1.08B $ 259M $ 261.9M Gross Profit $ 685.1M $ 164.1M $ 157.1M Net Income / Loss $ 52.8M $ 23.5M $ M Operating Income / Loss $ 173.7M $ 62.9M $ 28.7M Cost of Revenue $ 394.4M $ 94.9M $ 104.8M Net Cash Flow $ -90.9M $ $ PE Ratio 12.88